{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:46:19Z","timestamp":1792701979483,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.drup.2024.101117","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T18:14:50Z","timestamp":1719944090000},"page":"101117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Circulating tumor cells with increasing aneuploidy predict inferior prognosis and therapeutic resistance in small cell lung cancer"],"prefix":"10.1016","volume":"76","author":[{"given":"Zhongpeng","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Situ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinru","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongze","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huipin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsian-Rong","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunfu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.drup.2024.101117_bib1","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases","volume":"10","author":"Allard","year":"2004","journal-title":"Clin. Cancer Res"},{"issue":"15","key":"10.1016\/j.drup.2024.101117_bib2","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/cncr.30062","article-title":"Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1508)","volume":"122","author":"Belani","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.drup.2024.101117_bib3","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1038\/s41467-021-23965-5","article-title":"Homing in on genomic instability as a therapeutic target in cancer","volume":"12","author":"Bielski","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.drup.2024.101117_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","article-title":"Genome doubling shapes the evolution and prognosis of advanced cancers","volume":"50","author":"Bielski","year":"2018","journal-title":"Nat. Genet"},{"issue":"9","key":"10.1016\/j.drup.2024.101117_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ng1861","article-title":"A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers","volume":"38","author":"Carter","year":"2006","journal-title":"Nat. Genet"},{"issue":"36","key":"10.1016\/j.drup.2024.101117_bib6","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1200\/JCO.2009.25.6156","article-title":"Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer","volume":"27","author":"Chao","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2024.101117_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2021.06.002","article-title":"Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients","volume":"517","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"31","key":"10.1016\/j.drup.2024.101117_bib8","doi-asserted-by":"crossref","first-page":"35389","DOI":"10.1021\/acsami.2c08560","article-title":"Predictive value of circulating tumor cells based on subtraction enrichment for recurrence risk in stage ii colorectal cancer","volume":"14","author":"Chen","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.drup.2024.101117_bib9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann. Oncol."},{"issue":"1-2","key":"10.1016\/j.drup.2024.101117_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drup.2007.02.003","article-title":"Cancer drug resistance: the central role of the karyotype.","volume":"10","author":"Duesberg","year":"2007","journal-title":"Drug Resist Updat"},{"issue":"26","key":"10.1016\/j.drup.2024.101117_bib11","doi-asserted-by":"crossref","first-page":"14295","DOI":"10.1073\/pnas.97.26.14295","article-title":"Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy","volume":"97","author":"Duesberg","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.drup.2024.101117_bib12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.drup.2024.101117_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrg3123","article-title":"Causes and consequences of aneuploidy in cancer","volume":"13","author":"Gordon","year":"2012","journal-title":"Nat. Rev. Genet"},{"issue":"5","key":"10.1016\/j.drup.2024.101117_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PAP.0b013e3181832320","article-title":"Bladder cancer detection using FISH (UroVysion assay)","volume":"15","author":"Halling","year":"2008","journal-title":"Adv. Anat. Pathol."},{"issue":"1","key":"10.1016\/j.drup.2024.101117_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","article-title":"Survival model predictive accuracy and ROC curves","volume":"61","author":"Heagerty","year":"2005","journal-title":"Biometrics"},{"issue":"12","key":"10.1016\/j.drup.2024.101117_bib16","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jtho.2021.07.018","article-title":"Overcoming Chemotherapy Resistance in SCLC","volume":"16","author":"Herzog","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.drup.2024.101117_bib17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/ijc.31742","article-title":"Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma","volume":"144","author":"He","year":"2019","journal-title":"Int J. Cancer"},{"issue":"11","key":"10.1016\/j.drup.2024.101117_bib18","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/annonc\/mds138","article-title":"Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor","volume":"23","author":"Hiltermann","year":"2012","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.drup.2024.101117_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2010.33.3716","article-title":"Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer","volume":"30","author":"Hou","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.drup.2024.101117_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813926","article-title":"Tetraploidization increases the motility and invasiveness of cancer cells","volume":"24","author":"Jema\u00e0","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2024.101117_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100929","article-title":"Sunitinib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers","volume":"67","author":"Jin","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"166","key":"10.1016\/j.drup.2024.101117_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0151-2022","article-title":"Circulating tumour cells in patients with lung cancer universally indicate poor prognosis","volume":"31","author":"Jin","year":"2022","journal-title":"Eur. Respir. Rev."},{"issue":"10","key":"10.1016\/j.drup.2024.101117_bib23","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.6004\/jnccn.2018.0079","article-title":"NCCN guidelines insights: small cell lung cancer, Version 2.2018","volume":"16","author":"Kalemkerian","year":"2018","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"2","key":"10.1016\/j.drup.2024.101117_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1574892817666220629104641","article-title":"Nanomaterials for diagnosis and treatment of lung cancer: a review of recent patents","volume":"18","author":"Kaur","year":"2022","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"1","key":"10.1016\/j.drup.2024.101117_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1158\/1078-0432.CCR-15-1008","article-title":"Early changes in circulating tumor cells are associated with response and survival following treatment of metastatic neuroendocrine neoplasms","volume":"22","author":"Khan","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2024.101117_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2019.07.004","article-title":"Immune checkpoint inhibitor combinations: current efforts and important aspects for success","volume":"45","author":"Kon","year":"2019","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10.1016\/j.drup.2024.101117_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40169-015-0081-2","article-title":"Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells","volume":"4","author":"Lin","year":"2015","journal-title":"Clin. Transl. Med"},{"issue":"1","key":"10.1016\/j.drup.2024.101117_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1574892817666220308090954","article-title":"The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment","volume":"18","author":"Li","year":"2023","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.drup.2024.101117_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100904","article-title":"Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment","volume":"66","author":"Li","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"7","key":"10.1016\/j.drup.2024.101117_bib30","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/annonc\/mdy172","article-title":"Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts","volume":"29","author":"Lorente","year":"2018","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.drup.2024.101117_bib31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/annonc\/mdw122","article-title":"Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study","volume":"27","author":"Morrow","year":"2016","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.drup.2024.101117_bib32","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JTO.0b013e31823f125d","article-title":"Prognostic impact of circulating tumor cells in patients with small cell lung cancer","volume":"7","author":"Naito","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.drup.2024.101117_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092158","article-title":"Clinical relevance of mesenchymal- and stem-associated phenotypes in circulating tumor cells isolated from lung cancer patients","volume":"13","author":"Pantazaka","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.drup.2024.101117_bib34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ceb.2010.06.003","article-title":"Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer","volume":"22","author":"Pavelka","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.drup.2024.101117_bib35","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/1078-0432.CCR-23-1689","article-title":"Durvalumab \u00b1 tremelimumab + platinum-etoposide in extensive-stage small cell lung cancer (CASPIAN): outcomes by PD-L1 expression and tissue tumor mutational burden","volume":"30","author":"Paz-Ares","year":"2024","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2024.101117_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216187","article-title":"Circulating tumor cell abundance in head and neck squamous cell carcinoma decreases with successful chemoradiation and cetuximab treatment","volume":"562","author":"Poellmann","year":"2023","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.drup.2024.101117_bib37","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jtho.2020.01.016","article-title":"New approaches to SCLC therapy: from the laboratory to the clinic","volume":"15","author":"Poirier","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.drup.2024.101117_bib38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.annonc.2021.02.025","article-title":"Small cell lung cancer: a slightly less orphan disease after immunotherapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2024.101117_bib39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2018.01.011","article-title":"Clinical applications of the cellsearch platform in cancer patients","volume":"125","author":"Riethdorf","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.drup.2024.101117_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrclinonc.2017.198","article-title":"Determinants and clinical implications of chromosomal instability in cancer","volume":"15","author":"Sansregret","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6102","key":"10.1016\/j.drup.2024.101117_bib41","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1126\/science.1224922","article-title":"An immunosurveillance mechanism controls cancer cell ploidy","volume":"337","author":"Senovilla","year":"2012","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.drup.2024.101117_bib42","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/bjc.2014.218","article-title":"Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas","volume":"110","author":"Seo","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"7287","key":"10.1016\/j.drup.2024.101117_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature08803","article-title":"Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal","volume":"464","author":"Sotillo","year":"2010","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.drup.2024.101117_bib44","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s43018-022-00467-x","article-title":"Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade","volume":"3","author":"Spurr","year":"2022","journal-title":"Nat. Cancer"},{"issue":"22","key":"10.1016\/j.drup.2024.101117_bib45","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1158\/1078-0432.CCR-09-1095","article-title":"Circulating tumor cell as a diagnostic marker in primary lung cancer","volume":"15","author":"Tanaka","year":"2009","journal-title":"Clin. Cancer Res"},{"issue":"4","key":"10.1016\/j.drup.2024.101117_bib46","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","article-title":"Genomic and functional approaches to understanding cancer aneuploidy","volume":"33","author":"Taylor","year":"2018","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.drup.2024.101117_bib47","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/annonc\/mdz122","article-title":"Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial","volume":"30","author":"Tay","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2024.101117_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drup.2017.02.002","article-title":"Drug-biomarker co-development in oncology - 20 years and counting","volume":"30","author":"Twomey","year":"2017","journal-title":"Drug Resist Updat"},{"issue":"22","key":"10.1016\/j.drup.2024.101117_bib49","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41388-024-03027-y","article-title":"FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer","volume":"43","author":"Wang","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2024.101117_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2017.10.004","article-title":"Quantified postsurgical small cell size CTCs and EpCAM(+) circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse.","volume":"412","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2024.101117_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216337","article-title":"Longitudinal detection of subcategorized CD44v6(+) CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study","volume":"571","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.drup.2024.101117_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2006.12.003","article-title":"Aneuploidy acts both oncogenically and as a tumor suppressor","volume":"11","author":"Weaver","year":"2007","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.drup.2024.101117_bib53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.21037\/jtd-22-73","article-title":"Comprehensive analysis of aneuploidy status and its effect on the efficacy of EGFR-TKIs in lung cancer","volume":"14","author":"Wei","year":"2022","journal-title":"J. Thorac. Dis."},{"issue":"2","key":"10.1016\/j.drup.2024.101117_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00008571-200103000-00006","article-title":"Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility","volume":"11","author":"Wikman","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"4","key":"10.1016\/j.drup.2024.101117_bib55","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/15384047.2018.1538000","article-title":"Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies","volume":"20","author":"Ye","year":"2019","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.drup.2024.101117_bib56","first-page":"673","article-title":"Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response","volume":"5","author":"Young","year":"1999","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.drup.2024.101117_bib57","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1186\/s12885-018-5034-x","article-title":"Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.drup.2024.101117_bib58","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/1878-0261.13092","article-title":"Role of aneuploid circulating tumor cells and CD31(+) circulating tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced NSCLC","volume":"15","author":"Zhang","year":"2021","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2024.101117_bib59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41392-023-01725-9","article-title":"New insights into the correlations between circulating tumor cells and target organ metastasis","volume":"8","author":"Zhan","year":"2023","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136876462400075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136876462400075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T22:38:37Z","timestamp":1723588717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S136876462400075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":59,"alternative-id":["S136876462400075X"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2024.101117","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating tumor cells with increasing aneuploidy predict inferior prognosis and therapeutic resistance in small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2024.101117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101117"}}